vikram deshpande
vikram deshpande
Associate Professor of Pathology, Harvard Medical School
Verified email at partners.org
TitleCited byYear
IgG4-related disease
JH Stone, Y Zen, V Deshpande
New England Journal of Medicine 366 (6), 539-551, 2012
19192012
Consensus statement on the pathology of IgG4-related disease
V Deshpande, Y Zen, JKC Chan, EY Eunhee, Y Sato, T Yoshino, ...
Modern Pathology 25 (9), 1181, 2012
15652012
Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations
JH Stone, A Khosroshahi, V Deshpande, JKC Chan, JG Heathcote, ...
Arthritis & Rheumatism 64 (10), 3061-3067, 2012
5612012
Autoimmune pancreatitis
DL Finkelberg, D Sahani, V Deshpande, WR Brugge
New England Journal of Medicine 355 (25), 2670-2676, 2006
5592006
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease
A Khosroshahi, DB Bloch, V Deshpande, JH Stone
Arthritis & Rheumatism 62 (6), 1755-1762, 2010
4982010
Frequent mutation of isocitrate dehydrogenase (IDH) 1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
DR Borger, KK Tanabe, KC Fan, HU Lopez, VR Fantin, KS Straley, ...
The oncologist 17 (1), 72-79, 2012
4722012
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients
A Khosroshahi, MN Carruthers, V Deshpande, S Unizony, DB Bloch, ...
Medicine 91 (1), 57-66, 2012
4482012
Genome-wide chromatin state transitions associated with developmental and environmental cues
J Zhu, M Adli, JY Zou, G Verstappen, M Coyne, X Zhang, T Durham, ...
Cell 152 (3), 642-654, 2013
4342013
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
ÖH Yilmaz, P Katajisto, DW Lamming, Y Gültekin, KE Bauer-Rowe, ...
Nature 486 (7404), 490, 2012
4142012
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer
CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ...
Annals of surgery 261 (1), 12, 2015
3942015
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus
W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ...
PLoS genetics 6 (2), e1000841, 2010
3732010
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers
DT Ting, D Lipson, S Paul, BW Brannigan, S Akhavanfard, EJ Coffman, ...
Science 331 (6017), 593-596, 2011
3512011
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set
DS Klimstra, IR Modlin, NV Adsay, R Chetty, V Deshpande, M Gönen, ...
The American journal of surgical pathology 34 (3), 300-313, 2010
3512010
Autoimmune pancreatitis: a systemic immune complex mediated disease
V Deshpande, S Chicano, D Finkelberg, MK Selig, M Mino-Kenudson, ...
The American journal of surgical pathology 30 (12), 1537-1545, 2006
3252006
Rituximab for IgG4-related disease: a prospective, open-label trial
MN Carruthers, MD Topazian, A Khosroshahi, TE Witzig, ZS Wallace, ...
Annals of the rheumatic diseases 74 (6), 1171-1177, 2015
3232015
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
RM Perera, S Stoykova, BN Nicolay, KN Ross, J Fitamant, M Boukhali, ...
Nature 524 (7565), 361, 2015
3212015
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
MN Carruthers, A Khosroshahi, T Augustin, V Deshpande, JH Stone
Annals of the rheumatic diseases 74 (1), 14-18, 2015
3082015
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
ZS Wallace, H Mattoo, M Carruthers, VS Mahajan, E Della Torre, H Lee, ...
Annals of the rheumatic diseases 74 (1), 190-195, 2015
3002015
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis
RB Corcoran, G Contino, V Deshpande, A Tzatsos, C Conrad, CH Benes, ...
Cancer research 71 (14), 5020-5029, 2011
2952011
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection?
IT Konstantinidis, AL Warshaw, JN Allen, LS Blaszkowsky, ...
Annals of surgery 257 (4), 731-736, 2013
2922013
The system can't perform the operation now. Try again later.
Articles 1–20